Good morning, everyone. My name is Dina Elmonshed, one of the U.S. biotech analysts here at UBS. And joining me today is the President and CEO of Vertex Pharmaceuticals, Reshma Kewalramani. Thank you ...
Prima Additive has formally rebranded as AltForm, marking a strategic shift in focus from metal 3D printing toward a broader ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback